Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Sweden

TLV makes binding outpatient price and subsidy decisions. Selected hospital medicines use TLV health-economic assessment, NT Council recommendation, regional implementation and procurement.

EC/EMA or Läkemedelsverket
company / TLV / regional managed-introduction system
TLV analysts / regions / applicant
Pharmaceutical Benefits Board / TLV / regions / company
prescriber / pharmacy / e-health systems / patient
8 decision nodes13 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it